Helmerich and Payne Inc (HP) Stock Analysis

Verdict: AVOID

KCA Deutag scale boosts revenue, but 4 straight EPS misses and $2.32B debt cap upside above consensus target of $43.60.

Investment score: 37/100

Analysis as of

Is Helmerich and Payne Inc stock worth reviewing? AI model thesis

The model views Helmerich & Payne as overextended following its 28.4% 30-day rally to $45.02. While revenue grew 16.57% in FY25 due to the KCA Deutag integration, four consecutive earnings misses and $2.32B in total debt outweigh near-term price momentum.

7-factor investment score

Helmerich and Payne Inc opportunities and risks

What speaks for HP

What speaks against HP

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
HPn/a1.1x7.7x10.5%-3.4%7.0%
NE49.0x2.4x9.7x26.7%4.9%3.8%
PTENn/a1.0x6.9x14.2%-1.9%3.7%
NE49.0x2.4x9.7x26.7%4.9%3.8%
AASPn/a0.0xn/a0.0%0.0%-4.0%
KEGXn/a0.1xn/a5.7%-23.5%-151.9%
Peer mediann/a1.0x6.9x14.2%0.0%3.7%

Frequently asked questions about Helmerich and Payne Inc (HP)

Is HP stock a good investment?

The cached TradeMates AI model rates Helmerich and Payne Inc as AVOID with an investment score of 37/100. The model views Helmerich & Payne as overextended following its 28.4% 30-day rally to $45.02. While revenue grew 16.57% in FY25 due to the KCA Deutag integration, four consecutive earnings misses and $2.32B in total debt outweigh near-term price momentum. This is algorithmic model output, not personal investment advice.

Is HP stock a buy?

The TradeMates model verdict for HP is AVOID with an investment score of 37/100. Treat this as a model signal to review, not a personal buy recommendation.